β-funaltrexamine inhibits inducible nitric-oxide synthase expression in human astroglial cells

Journal of Neuroimmune Pharmacology

Volumn 3, Issue 3, 2008, Pages 150-153

  Davis, Randall L ^a   Buck, Daniel J ^a   Saffarian, Neda ^a   Mohan, Shekher ^a   DeSilva, Udaya ^b   Fernando, Samodha C ^b   Stevens, Craig W ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Astrocytes; Fentanyl; Morphine; Neuroinflammation; Nitric oxide; Opioids

Indexed keywords

EID: 49549097325     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-008-9102-x     Document Type: Article

References (15)

1. Davis RL, Syapin PJ (2004) Acute ethanol exposure modulates expression of inducible nitric-oxide synthase in human astroglia: evidence for a transcriptional mechanism. Alcohol 32:195-202
2. Davis RL, Dertien J, Syapin PJ (2002) Ethanol-induced modulation of inducible nitric-oxide synthase activity in human A172 astrocytoma cells. Alcohol Clin Exp Res 26:1404-1411
3. Davis RL, Buck DJ, Saffarian N, Stevens CW (2007) The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human astroglial cells. J Neuroimmunol 186:141-149
4. Hettinger AM, Allen MR, Zhang BR, Goad DW, Malayer JR, Geisert RD (2001) Presence of the acute phase protein, bikunin, in the endometrium of gilts during estrous cycle and early pregnancy. Biol Reprod 65:507-513
5. Jafarian-Tehrani M, Louin G, Royo NC, Besson VC, Bohme GA, Plotkine M, Marchand-Verrecchia C (2005) 1400W, a potent selective inducible NOS inhibitor, improves histopathological outcome following traumatic brain injury in rats. Nitric Oxide 12:61-69
6. Lee J, Kim MS, Park C, Jung EB, Choi DH, Kim TY, Moon SK, Park R (2004) Morphine prevents glutamate-induced death of primary rat neonatal astrocytes through modulation of intracellular redox. Immunopharmacol Immunotoxicol 26:17-28
7. Liu B, Du L, Hong JS (2000) Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J Pharmacol Exp Ther 293:607-617
8. Liu Y, Qin L, Wilson BC, An L, Hong JS, Liu B (2002) Inhibition by naloxone stereoisomers of beta-amyloid peptide (1-42)-induced superoxide production in microglia and degeneration of cortical and mesencephalic neurons. J Pharmacol Exp Ther 302:1212-1219
9. Louin G, Marchand-Verrecchia C, Palmier B, Plotkine M, Jafarian-Tehrani M (2006) Selective inhibition of inducible nitric oxide synthase reduces neurological deficit but not cerebral edema following traumatic brain injury. Neuropharmacology 50:182-190
10. Marchetti B, Serra PA, Tirolo C, L'Episcopo F, Caniglia S, Gennuso F, Testa N, Miele E, Desole S, Barden N, Morale MC (2005) Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental parkinsonism: pivotal role for glia-neuron interactions. Brain Res Brain Res Rev 48:302-321
11. Poluektova L, Meyer V, Walters L, Paez X, Gendelman HE (2005) Macrophage-induced inflammation affects hippocampal plasticity and neuronal development in a murine model of HIV-1 encephalitis. Glia 52:344-353
12. Qi JA, Heyman JS, Sheldon RJ, Koslo RJ, Porreca F (1990) Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice. J Pharmacol Exp Ther 252:1006-1011
13. Ruzicka BB, Fox CA, Thompson RC, Meng F, Watson SJ, Akil H (1995) Primary astroglial cultures derived from several rat brain regions differentially express mu, delta and kappa opioid receptor mRNA. Brain Res Mol Brain Res 34:209-220
14. Zhao H, Huang HW, Wu GC, Cao XD (2002) Effect of orphanin FQ on interleukin-1beta mRNA transcripts in the rat CNS. Neuroscience 114:1019-1031
15. Zhao P, Huang Y, Zuo Z (2006) Opioid preconditioning induces opioid receptor-dependent delayed neuroprotection against ischemia in rats. J Neuropathol Exp Neurol 65:945-952